About BioLife Solutions, Inc. - Common Stock (BLFS)
Biolife Solutions is a biotechnology company that specializes in the development and commercialization of innovative biopreservation products and services designed to improve the storage and transportation of cells, tissues, and organs. The company focuses on providing high-quality, cost-effective solutions that enhance the viability and functionality of biological samples, crucial for advancements in regenerative medicine, cell therapy, and clinical applications. By leveraging its proprietary technologies, Biolife Solutions aims to support the growing demand for safe and efficient biobanking and biopreservation practices across the healthcare and pharmaceutical sectors. Read More
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen common stock.
